biomarker-trends-header.png

FDA Introduces a New Test Concept: "Complementary Diagnostics"

During a recent panel discussion regarding the regulation of laboratory-developed tests (LDTs), Elizabeth Mansfield, Deputy Director for Personalized Medicine at FDA, announced that FDA will be increasingly focused on what she called "complementary diagnostics."

   

March

Webinar: 

Pharmacovigilance and Safety Biomarkers

RECORDING
New Call-to-action
FREE REPORT

Subscribe for Updates

Download our Free IVD Trends Report